Who Gains Most? A 10-Year Experience With 611 Thoracoscopic Talc Pleurodeses Volker Steger, MD, Ute Mika, Heikki Toomes, MD, Tobias Walker, MD, Corinna Engel, Thomas Kyriss, MD, Gerhard Ziemer, MD, Godehard Friedel, MD The Annals of Thoracic Surgery Volume 83, Issue 6, Pages 1940-1945 (June 2007) DOI: 10.1016/j.athoracsur.2007.02.061 Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Survival analysis according to a Karnofsky index that exceeds 60% (solid line) compared with a Karnofsky index of 60% or less (dashed line; p < 0.0001). The Annals of Thoracic Surgery 2007 83, 1940-1945DOI: (10.1016/j.athoracsur.2007.02.061) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Survival analysis breast cancer (dashed line) compared with all other malignancies (solid line; p = 0.0056). The Annals of Thoracic Surgery 2007 83, 1940-1945DOI: (10.1016/j.athoracsur.2007.02.061) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Survival analysis malignant disease (dashed line) compared with benign disease (solid line; p < 0.0001). The Annals of Thoracic Surgery 2007 83, 1940-1945DOI: (10.1016/j.athoracsur.2007.02.061) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions